FDA NDC Directory · JSON-LD · Markdown

Nalbuphine hydrochloride

NDC 70069-662 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerSomerset Therapeutics, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA216049
Dosage form / routeINJECTION · INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active ingredientsNALBUPHINE HYDROCHLORIDE (20 mg/mL)
Marketing started20240926
Package count1

External sources

Source: openFDA. Public-domain (CC0).